COVID-19 is an emerging, rapidly evolving siituation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

CPTAC Investigators Discuss Research Insights and Perspectives as part of ASBMB Journal Club - 12 Nov

On Wednesday, November 12, 2014 from 2:00 PM to 3:00 PM EST, Daniel Liebler, PhD (Vanderbilt University) and Karin Rodland, PhD (Pacific Northwestern National Laboratory) and Ruedi Aebersold, PhD (Swiss Federal Institute of Technology) will share their research insight as part of the ASBMB Journal Club.  Both Doctors Liebler and Rodland are Principal Investigators in the NCI’s Clinical Proteomic Tumor Analysis Consortium.

This free event will focus on Biomarkers: Discovery, validation and applications and can be watched live using Google+. The researchers will be taking questions and comments regarding their research and technological developments in proteomics that are assisting in efforts to translate research findings to clinical applications.

The American Society for Biochemistry and Molecular Biology are the sponsors for the Journal Club and the NCI is sharing this information as a service to the proteomics community.